Filing Details
- Accession Number:
- 0001179022-10-000061
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2010-10-22 16:02:04
- Reporting Period:
- 2009-09-30
- Filing Date:
- 2010-10-22
- Accepted Time:
- 2010-10-22 16:02:04
- Original Submission Date:
- 2009-10-02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1010086 | Siga Technologies Inc | SIGA | Pharmaceutical Preparations (2834) | 133864870 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1275596 | M M Adnan Mjalli | C/O Transtech Pharma, Inc. 4170 Mendenhall Oaks Parkway, Suite 110 High Point NC 27265 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share ("Common Stock") | Acquisiton | 2009-09-30 | 1,845,396 | $1.88 | 4,317,618 | No | 4 | X | Indirect | by TransTech Pharma, Inc. |
| Common Stock | Disposition | 2009-09-30 | 444,666 | $7.80 | 3,872,952 | No | 4 | F | Indirect | by TransTech Pharma, Inc. |
| Common Stock | Disposition | 2009-09-30 | 3,851,969 | $6.24 | 20,983 | No | 4 | S | Indirect | by TransTech Pharma, Inc. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Indirect | by TransTech Pharma, Inc. |
| No | 4 | F | Indirect | by TransTech Pharma, Inc. |
| No | 4 | S | Indirect | by TransTech Pharma, Inc. |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (right to buy) | Disposition | 2009-09-30 | 1,845,396 | $0.00 | 1,845,396 | $1.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2004-01-08 | 2011-01-08 | No | 4 | X | Indirect |
Footnotes
- On September 30, 2009, TransTech Pharma, Inc. sold 3,851,969 shares of Common Stock in a privately negotiated transaction to STH Partners, L.P.
- The shares of Common Stock and the warrants were beneficially owned by TransTech Pharma, Inc. The reporting person is the President, Chief Executive Officer and a director of TransTech Pharma, Inc. The reporting person disclaims beneficial ownership of the securities beneficially owned by TransTech Pharma, Inc. except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
